10 stories about Opioid
קור שולץ מנכ"ל חברת טבע תרופות 23.8.20

Why are investors so pleased about Teva's $4.35 billion opioid settlement?

27.07.22|Sophie Shulman
The settlement removes the cloud of uncertainty that hovered over Teva, which on the one hand prevented investors from placing trust in its stock, while on the other hand also prevented Teva management from making substantial moves
חוגו חדש חברת תרופות טבע

Teva reaches $4.35 billion settlement in U.S. opioid lawsuits, shares surge

27.07.22|Sophie Shulman and Reuters
Teva is set to pay state and local governments up to $3.7 billion in cash over 13 years plus a contribution of $1.2 billion worth of the opioid overdose reversal drug naloxone
מושל ניו יורק אנדרו קואומו

Double trouble for Teva as NY State files charges on same day as DOJ

Governor Andrew M. Cuomo announced that the New York State Department of Financial Services has initiated administrative proceedings against Teva in connection with the Opioid Crisis
מטה חברת טבע תרופות

Teva Announces $23.25 Billion Opioid Abuse Settlement Agreement

22.10.19|Lilach Baumer
Teva announced on Monday a settlement with both Cuyahoga and Summit counties of Ohio, averting the trial scheduled for later that day, and an agreement in principle for a global settlement framework
אתר טבע כפר סבא

Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says

16.10.19|Hezi Sternlicht
The Israeli drugmaker and several other drug distributors are set to face around 2,500 lawsuits related to the U.S. opioid abuse epidemic in just a week at a Cleveland, Ohio federal court
מטה חברת טבע תרופות

Judge Rejects Teva’s Request to Be Tried Separately in U.S. Opioid Case, Report Says

Teva made a last minute attempt to be tried separately in opioid abuse damages case set to be held on October 21 in federal court in Cleveland, Ohio
אתר טבע כפר סבא

Court Approves One Teva Opioid Settlement, Many More to Come

25.06.19|Hezi Sternlicht
The settlement will see Teva will pay Oklahoma a one-time payment of $85 million to settle claims that it had played a role in exacerbating the U.S. opioid use epidemic there
תרופה תרופות סל התרופות

Israel Leads OECD Countries on Opioid Use Increase, Says Report

19.05.19|Adrian Filut
Between 2011 and 2016, the availability of opioids in Israel grew by 125%, according to an OECD report published over the weekend
מטה טבע פתח תקווה

FDA Approves Teva’s Generic Nasal Spray for Opioid Overdose

21.04.19|Lilach Baumer
Commonly known as Narcan, the spray is considered a life-saving medication, and Teva’s drug is the first generic product approved that does not require medical training to use
מפעל טבע הר חוצבים ירושלים

Bidder Contests Teva Sale of Jerusalem Facility

31.03.19|Amitai Gazit and Lilach Baumer
Earlier this month, Teva agreed to sell the land tenure rights of its two Jerusalem factories, set to close by the end of 2019, for a combined $77 million